HMNC Brain Health to Present at CNS Summit on Precision Psychiatry
31 Oct 2024 //
GLOBENEWSWIRE
Maximilian Doebler Appointed Chief Business Officer of HMNC Brain Health
22 Aug 2022 //
GLOBENEWSWIRE
First patient dosed in second Phase 2 add-on Ketamine Trial in TRD
08 Jun 2022 //
GLOBENEWSWIRE
HMNC Brain Health to Participate in Upcoming Investor Conferences in April 2022
11 Apr 2022 //
GLOBENEWSWIRE
Prolonged-release ketamine advances after COVID-disrupted trial
06 Apr 2022 //
FIERCEPHARMA
HMNC Brain Health Appoints Dr. Bertram as Head of Precision Psychiatry
24 Feb 2022 //
GLOBENEWSWIRE